iBio is developing proteins for use in cutting-edge research and cGMP manufacturing where the demand for high-quality products continues to evolve.
Using the FastPharming System®, iBio is producing animal-free proteins with a high impact across innovative fields, such as 3D-bioprinting, cell therapy, and tissue engineering. With FastPharming, the feasibility of expressing untested proteins can be evaluated in as soon as three weeks.
iBio offers development services for intracellular and secreted proteins, such as:
- Growth Factors